December 5, 2017 | Philadelphia, PA
www.cbinet.com/drugpricing
With numerous states across the country ramping up on introducing and passing laws aimed at drug pricing transparency and reporting, is your organization prepared to act? And fast? The recent passage of California’s drug pricing bill and a number of other states passing laws earlier in 2017 leaves many unanswered questions and the opportunity to steer the course is now.
Exclusive Offer for Drug Channels Readers: Save $300 when you use discount code DCP125 and register by November 17, 2017.
CBI’s one-day Drug Pricing Transparency Congress, taking place December 5th in Philadelphia, convenes stakeholders across the healthcare ecosystem, including state and federal government regulators, manufacturers, health plans, PBMs, associations and other industry experts to learn how the future of drug pricing transparency regulation impacts commercialization, reimbursement and drug pricing models with a focus on state pricing and transparency regulation.
This monumental shift will undoubtedly impact so many functions across the healthcare system. If your responsibilities touch any facet of your organization's pricing, transparency or commercialization efforts, you'll need to be on the pulse of the rapid developments and this conference will serve as an unparalleled uniting place for the industry to assess the future landscape and gain clarity on the many unanswered questions from industry experts and regulators.
Don't be left out of the critical conversation.
Exclusive Offer for Drug Channels Readers: Save $300 when you use discount code DCP125 and register by November 17, 2017.
*Offer expires November 17, 2017; applies to standard rates only and may not be combined with other offers, category rates, and promotions or applied to an existing registration.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment